Cargando…
Development of a cell-free screening assay for the identification of direct PERK activators
The activation of the unfolded protein response, particularly via the PERK pathway, has been suggested as a promising therapeutic approach in tauopathies, a group of neurodegenerative disorders characterized by the abnormal phosphorylation and aggregation of tau protein. So far, a shortage of availa...
Autores principales: | Costa, Márcia F. D., Höglinger, Günter U., Rösler, Thomas W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194977/ https://www.ncbi.nlm.nih.gov/pubmed/37200357 http://dx.doi.org/10.1371/journal.pone.0283943 |
Ejemplares similares
-
PERK activation mitigates tau pathology in vitro and in vivo
por: Bruch, Julius, et al.
Publicado: (2017) -
Identification and Characterization of PERK Activators by Phenotypic Screening and Their Effects on NRF2 Activation
por: Xie, Wensheng, et al.
Publicado: (2015) -
Identification and Validation of Novel PERK Inhibitors
por: Wang, Qiantao, et al.
Publicado: (2014) -
Neuronal precursor cells with dopaminergic commitment in the rostral migratory stream of the mouse
por: Schweyer, Kerstin, et al.
Publicado: (2019) -
Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells
por: Höllerhage, Matthias, et al.
Publicado: (2017)